Elite Laboratories, Inc. secured FDA approval for its generic Acetaminophen and Codeine Phosphate tablets (ANDA 212418), opening a pathway to capture market share in the established pain management sector. The launch of this generic alternative is anticipated to bolster the company's revenue growth and broaden its existing product portfolio.